US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Haemonetics

63.85

+0.86001.37%

Post-market: 63.850.00000.00%16:20 EDT

Volume:534.76K

Turnover:34.19M

Market Cap:3.21B

PE:25.15

High:64.42

Open:63.77

Low:63.33

Close:62.99

Loading ...

Overview Company News Filings

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Haemonetics (HAE) Earnings Expected to Grow: Should You Buy?

Astria Therapeutics Announces Publication of Navenibart Phase 1a Healthy Subject Results in the Annals of Allergy, Asthma & Immunology

4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates

Ionis reports first quarter 2025 financial results

KalVista Pharmaceuticals to Present at the Citizens Life Sciences Conference

New Harris Poll findings reveal HAE patients are unsatisfied with current prophylactic treatment options, with over 90% interested in trying new therapies

1 Profitable Stock Worth Your Attention and 2 to Question

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

Medical Devices & Supplies - Specialty Stocks Q3 Recap: Benchmarking STAAR Surgical (NASDAQ:STAA)

Pharvaris Reports 2024 Financial Results and Advances HAE Treatment Studies

Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

3 Stocks That May Be Trading Below Their Estimated Value In April 2025

Simply Wall St.

3 Reasons to Avoid HAE and 1 Stock to Buy Instead

Is Intellia Therapeutics, Inc. (NTLA) the Best Gene-Editing Stock to Buy?

Pharvaris Announces Orphan Designation Granted to Deucrictibant by the European Commission

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025

3 Promising Value Stocks Estimated To Be 13.1% To 46.3% Below Intrinsic Value

Simply Wall St.

Driven Brands Holdings Among 3 Stocks Priced Below Estimated Fair Value

Simply Wall St.

March 2025 Value Equities That Could Be Trading Below Estimated Worth

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HAE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HAE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HAE\",,,,,undefined,":{"symbol":"HAE","market":"US","secType":"STK","nameCN":"Haemonetics","latestPrice":63.85,"timestamp":1746216000000,"preClose":62.99,"halted":0,"volume":534756,"hourTrading":{"tag":"盘后","latestPrice":63.85,"preClose":63.85,"latestTime":"16:20 EDT","volume":13886,"amount":886620.12,"timestamp":1746217200452},"delay":0,"floatShares":49750885,"shares":50237466,"eps":2.538856,"marketStatus":"Market Closed","change":0.86,"latestTime":"05-02 16:00:00 EDT","open":63.77,"high":64.42,"low":63.33,"amount":34191185.276004,"amplitude":0.017304,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.538856,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":673761600000,"exchange":"NYSE","adjPreClose":62.99,"preHourTrading":{"tag":"盘前","latestPrice":64.99,"preClose":62.99,"latestTime":"05:55 EDT","volume":26,"amount":1672.7399,"timestamp":1746179700810},"postHourTrading":{"tag":"盘后","latestPrice":63.85,"preClose":63.85,"latestTime":"16:20 EDT","volume":13886,"amount":886620.12,"timestamp":1746217200452},"volumeRatio":1.175418112144693,"impliedVol":0.6341,"impliedVolPercentile":0.852},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HAE\",,,,,undefined,":{"symbol":"HAE","floatShares":49750885,"roa":"6.33%","roe":"14.06%","lyrEps":2.318423,"volumeRatio":1.175418112144693,"shares":50237466,"dividePrice":0,"high":64.42,"amplitude":0.017304,"preClose":62.99,"low":63.33,"week52Low":55.3,"pbRate":"3.54","psRate":"2.34","week52High":97.97,"institutionHeld":0.9196,"latestPrice":63.85,"eps":2.538856,"divideRate":0,"volume":534756,"delay":0,"ttmEps":2.538856,"open":63.77,"prevYearClose":78.08,"prevWeekClose":62.51,"prevMonthClose":63.02,"prevQuarterClose":63.55,"fiveDayClose":62.51,"twentyDayClose":62.22,"sixtyDayClose":71.24,"earningDate":1746633600000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HAE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532812327","title":"KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2532812327","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532812327?lang=en_us&edition=fundamental","pubTime":"2025-05-02 19:00","pubTimestamp":1746183600,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass. & SALISBURY, England, May 02, 2025----KalVista Pharmaceuticals, Inc. , today announced that the compensation committee of KalVista’s board of directors granted three newly-hired employees inducement options to purchase an aggregate of 14,000 shares of KalVista common stock on May 1, 2025 as inducements material to each employee entering into employment with KalVista. The options have an exercise price that is equal to the closing price of KalVista common stock on the grant date.One-fourth of the options vest on the one-year anniversary of the vesting commencement date and the remainder vest in equal monthly installments over the next three years, in each case subject to the new employee’s continued service with the company. Each stock option has a 10-year term and is subject to the terms and conditions of KalVista’s Inducement Equity Incentive Plan and a stock option agreement covering the grant.The options were granted in accordance with Nasdaq Listing Rule 5635.KalVi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kalvista-pharmaceuticals-reports-inducement-grants-110000873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B64QTZ34.USD","IE00BKPKM429.USD","KALV","LU2095319765.USD","IE00BGHQF748.EUR","NDAQ","USJW.SI","QID","USAW.SI","SQQQ","LU2210150020.SGD","BK4585","LU1169590202.USD","LU1169589451.USD","BK4588","QLD","IE00BLDYK493.USD","BK4139","IE00B64PRP62.GBP","NVIW.SI","BK4198","LU0205193047.USD","IE00B3QW5Z07.USD","PSQ","LU2210149790.SGD","BK4112","TQQQ","NQmain","LU0205194284.USD","TSYW.SI","HAE","LU0012050646.USD","LU0106261612.USD","MNQmain",".IXIC"],"gpt_icon":1},{"id":"2532007343","title":"Haemonetics (HAE) Earnings Expected to Grow: Should You Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2532007343","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532007343?lang=en_us&edition=fundamental","pubTime":"2025-05-01 22:01","pubTimestamp":1746108108,"startTime":"0","endTime":"0","summary":"Wall Street expects a year-over-year increase in earnings on lower revenues when Haemonetics  reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 8, 2025, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.This provider blood management systems for health care providers and blood collectors is expected to post quarterly earnings of $1.22 per share in its upcoming report, wh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/haemonetics-hae-earnings-expected-grow-140148912.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PAHC","HAE"],"gpt_icon":0},{"id":"2532071275","title":"Astria Therapeutics Announces Publication of Navenibart Phase 1a Healthy Subject Results in the Annals of Allergy, Asthma & Immunology","url":"https://stock-news.laohu8.com/highlight/detail?id=2532071275","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532071275?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:00","pubTimestamp":1746100800,"startTime":"0","endTime":"0","summary":"BOSTON, May 01, 2025----Astria Therapeutics, Inc. , a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that results from a Phase 1a trial in healthy subjects supporting navenibart’s potential to provide long-acting, safe, and effective attack prevention for hereditary angioedema  with dosing every 3 and 6 months have been published in the Annals of Allergy, Asthma & Immunology.\"We are thrilled by our publication in the Annals of Allergy, Asthma & Immunology and the opportunity to provide additional information that affirms our belief in navenibart’s potential to become the first-choice therapy for HAE,\" said Christopher Morabito, M.D., Chief Medical Officer at Astria Therapeutics. \"The Phase 1a trial in healthy subjects laid the foundation for the advancement of navenibart and charted a path toward initiating ALPHA-ORBIT, our currently enrolling pivotal Phase 3 trial. The Phase 3 program, designed to introduc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astria-therapeutics-announces-publication-navenibart-120000006.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ATXS","IE00B64QTZ34.USD","LU1169590202.USD","LU1169589451.USD","BK4198","IE00BLDYK493.USD","LU0205194284.USD","LU0205193047.USD","HAE","LU0012050646.USD","LU0106261612.USD","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2532812077","title":"4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2532812077","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532812077?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:27","pubTimestamp":1746098820,"startTime":"0","endTime":"0","summary":"The first-quarter reporting cycle is off to a positive start, with most companies beating on estimates. However, uncertainty about the overall macroeconomic picture continues to be a significant drag on the earnings outlook as a whole, prompting analysts to cut their estimates for future quarters. Meanwhile, the Medical sector’s earnings growth seems to outshine other sectors significantly. This sector can act as a cushion amid rising volatility across global markets due to increasing tariffs.The key medical product companies that have released their earnings so far showed continued recovery following a period of rising costs and supply-chain disruptions in 2024. The integration of artificial intelligence is likely to be a key driver for adoption of medical devices in 2025. Moreover, at-home medical solutions are likely to continue their growth trend this year as well. Although MedTech companies are likely to reflect unfavorable impact of rising tariffs going forward, majority of these","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/4-medtech-stocks-poised-outshine-112700494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GMED","HAE"],"gpt_icon":0},{"id":"2531936033","title":"Ionis reports first quarter 2025 financial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2531936033","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531936033?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:00","pubTimestamp":1746010800,"startTime":"0","endTime":"0","summary":"- Encouraging start to first independent launch with TRYNGOLZATM -. - Increasing 2025 financial guidance by more than 20% -. CARLSBAD, Calif., April 30, 2025----Ionis Pharmaceuticals, Inc.   today reported financial results for the first quarter ended March 31, 2025.Reconciliation of GAAP to non-GAAP basis contained later in this release.Revenue increased 10% in the first quarter of 2025 compared to the same period last year, driven by higher commercial revenue including new TRYNGOLZA product revenue following approval in late December and higher SPINRAZA and WAINUA royalty revenue. Operating expenses increased slightly in the first quarter of 2025 driven by commercialization efforts for TRYNGOLZA, donidalorsen and WAINUA. Increased 2025 financial guidance reflects recent successful licensing transactions:. TRYNGOLZATM , the first-ever treatment for adults living with familial chylomicronemia syndrome  as an adjunct to diet, generated net product sales of over $6 million in its first f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ionis-reports-first-quarter-2025-110000010.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4217","BK4156","SMA","LU1169590202.USD","HAE","IONS","BK4139","LU0012050646.USD","BK4198","BK4201","BK4202","EC","IE00B64QTZ34.USD","IE00BLDYK493.USD","LU0205194284.USD","AS","LU0106261612.USD","LU0205193047.USD","LU1169589451.USD"],"gpt_icon":0},{"id":"2531036881","title":"KalVista Pharmaceuticals to Present at the Citizens Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2531036881","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531036881?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:00","pubTimestamp":1746010800,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass. & SALISBURY, England, April 30, 2025----KalVista Pharmaceuticals, Inc. , today announced that the Company will participate in a fireside chat at the Citizens Life Sciences Conference on Wednesday, May 7, 2025 at 11:30 a.m. ET.A live webcast of the presentation will be available on the Company’s website at www.kalvista.com. An audio archive will be available on KalVista’s website for 30 days following the presentations.KalVista Pharmaceuticals, Inc., is a global biopharmaceutical company dedicated to developing and delivering life-changing oral therapies for individuals affected by rare diseases with significant unmet needs. Our lead investigational product is sebetralstat, a novel, oral, on-demand treatment for hereditary angioedema . Sebetralstat is under regulatory review by the U.S. FDA, with a PDUFA goal date of June 17, 2025. In addition, we have completed Marketing Authorization Applications for sebetralstat to the European Medicines Agency and multiple other glo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kalvista-pharmaceuticals-present-citizens-life-110000045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BLDYK493.USD","BK4198","LU0106261612.USD","KALV","LU0205193047.USD","LU1169590202.USD","LU0012050646.USD","LU1169589451.USD","HAE","IE00B64QTZ34.USD","BK4139","LU0205194284.USD"],"gpt_icon":0},{"id":"2531786969","title":"New Harris Poll findings reveal HAE patients are unsatisfied with current prophylactic treatment options, with over 90% interested in trying new therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2531786969","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531786969?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:00","pubTimestamp":1745924400,"startTime":"0","endTime":"0","summary":"– Despite currently available treatment options, the majority of surveyed adults with HAE reported making tradeoffs in their daily lives due to the unexpected and unpredictable nature of HAE attacks –。– Opportunity exists for more consistent use of tools to support transparent communications between patients and their doctors, as HCPs may underestimate the full burden of HAE –。HAE is a rare and potentially life-threatening genetic condition that involves recurrent attacks of severe swelling  in various parts of the body, including the hands, feet, genitals, stomach, face and/or throat. A majority (72%) of patients in the survey said they made tradeoffs in their daily lives because they were not able to predict when they might have an attack. Despite most (85%) HCPs reporting that they understood how much HAE impacts their patients’ day-to-day lives, 60% of patients who have seen an HCP for their HAE wished their HCPs better understood this impact.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/harris-poll-findings-reveal-hae-110000028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4198","IE00BLDYK493.USD","BK4139","LU1169589451.USD","LU0012050646.USD","HAE","LU0205193047.USD","IE00B64QTZ34.USD","LU0205194284.USD","LU1169590202.USD","LU0106261612.USD","IONS"],"gpt_icon":0},{"id":"2530452762","title":"1 Profitable Stock Worth Your Attention and 2 to Question","url":"https://stock-news.laohu8.com/highlight/detail?id=2530452762","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530452762?lang=en_us&edition=fundamental","pubTime":"2025-04-28 01:13","pubTimestamp":1745773993,"startTime":"0","endTime":"0","summary":"A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.Not all profitable companies are created equal, and that’s why we built StockStory - to help you find the ones that truly shine bright. Keeping that in mind, here is one profitable company that leverages its financial strength to beat the competition and two that may face some trouble.Sales trends were unexciting over the last five years as its 6.6% annual growth was below the typical healthcare company. Subscale operations are evident in its revenue base of $1.37 billion, meaning it has fewer distribution channels than its larger rivals. Forecasted revenue decline of 4.7% for the upcoming 12 months implies demand will fall off a cliff. Projected sales growth of 1.8% for the next 12 months suggests sluggish demand. ROIC of 6.4% reflects management’s challenges in identifying attractive investment opportunities, and i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/1-profitable-stock-worth-attention-171313637.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1989764748.USD","BK4086","LU1121112475.USD","BK4588","JCI","HAE","IE00B64QTZ34.USD","SG9999004303.SGD","LU0345774391.USD","IE00BSNM7G36.USD","LU2471134523.USD","IE00B19Z9P08.USD","BK4504","LU0106261612.USD","LU0203345920.USD","LU1699723380.USD","LU0205193047.USD","LU0557290698.USD","LU1854103824.USD","BK4580","LU1267930573.SGD","LU1571399168.USD","LU0203347892.USD","BK4585","LU0208291251.USD","BK4142","BK4561","LU2750360997.AUD","IE00B3T34201.USD","IE00B5TLWC47.USD","LU0353189763.USD","LU1043141123.HKD","LU1496350502.SGD","LU2471134952.CNY","SGXZ23171101.USD","BK4548","LU1043141396.HKD","LU0029864427.USD","LU2237957902.USD","LU0205194284.USD","BKNG","LU1496350171.SGD","LU0012050646.USD","LU2471134879.HKD","LU0266013472.USD","LU0942090050.USD","LU0310800379.SGD","LU2750360641.GBP","LU0082616367.USD","LU1989764664.SGD"],"gpt_icon":0},{"id":"2526514519","title":"BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2526514519","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526514519?lang=en_us&edition=fundamental","pubTime":"2025-04-11 01:06","pubTimestamp":1744304764,"startTime":"0","endTime":"0","summary":"A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%, while the baseline 10% tariffs remained in place for most countries. This added layer of uncertainty reminded investors that the global trade environment remained volatile, limiting the potential for sustained market gains.Also President Trump indicated he was willing to accept pain in the short term, and was aware his policies could cause a recession, but he remained more mindful of a more severe case of economic depression .Access our full analysis report here, it’s free.Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own genera","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bd-teleflex-insulet-ufp-technologies-170604530.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4198","LU1169589451.USD","BK4082","LU1894683348.USD","LU1489326972.SGD","HAE","TFX","LU0728928796.USD","LU0289739343.SGD","LU0289961442.SGD","IE00B64QTZ34.USD","LU0433182093.SGD","BK4136","BK4588","LU0106261612.USD","BDX","BK4585","LU1571399168.USD","BK4504","LU1059921491.USD","LU1169590202.USD","IE00BFXG1179.USD","BK4551","LU0068578508.USD","LU1854104046.USD","LU0266013472.USD","IE00BLDYK493.USD","BK4566","LU2324357040.USD","LU0985320562.USD","PODD","LU0205194284.USD","LU1119994496.HKD","LU0012050646.USD","LU1150488218.USD","LU1261432733.SGD","LU0205193047.USD","LU1854103824.USD","LU0511384066.AUD","LU1150488135.SGD","LU1894683264.USD","LU0985489474.SGD","LU1084165304.USD","LU0878866978.SGD","UFPT"],"gpt_icon":0},{"id":"2525896095","title":"Medical Devices & Supplies - Specialty Stocks Q3 Recap: Benchmarking STAAR Surgical (NASDAQ:STAA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525896095","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525896095?lang=en_us&edition=fundamental","pubTime":"2025-04-08 17:04","pubTimestamp":1744103076,"startTime":"0","endTime":"0","summary":"As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including STAAR Surgical  and its peers.The 7 medical devices & supplies - specialty stocks we track reported a satisfactory Q3. As a group, revenues beat analysts’ consensus estimates by 0.9%.Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 21.4% since the latest earnings results.With over 2.5 million implants performed worldwide, STAAR Surgical  designs and manufactures implantable lenses that correct vision problems without removing the eye's natural lens.“In the third quarter, we achieved double-digit sales growth against a macroeconomic environment that softened in the second half of the quarter, particularly in China,” said Tom Frinzi, President and CEO of STAAR Surgical.Is now the time to buy STAAR Surgical?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medical-devices-supplies-specialty-stocks-090436686.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065731478.USD","NQmain","USJW.SI","INSP","IE00BKPKM429.USD","LU0012050646.USD","LU1169590202.USD","NVIW.SI","LU1169589451.USD","NDAQ","IE00B64QTZ34.USD","MNQmain","LU0106261612.USD","ITGR","BK4548","LU0205193047.USD",".IXIC","IE00B64PRP62.GBP","IE00BLDYK493.USD","GMED","IE0009354923.USD","LU0029874061.USD","BK4198","BK4082","HAE","STAA","LU1559883803.SGD","TSYW.SI","LU2210149790.SGD","BK4112","IE00B3QW5Z07.USD","BK4167","QLD","USAW.SI","LU0128526141.USD","LU1815336091.USD","IE00BGHQF748.EUR","PSQ","LU0566484027.USD","LU2095319765.USD","LU2210150020.SGD","QID","LU0757428866.USD","BK4585","SQQQ","BK4588","TQQQ","LU2065732104.USD","LU0205194284.USD"],"gpt_icon":1},{"id":"2525148730","title":"Pharvaris Reports 2024 Financial Results and Advances HAE Treatment Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2525148730","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525148730?lang=en_us&edition=fundamental","pubTime":"2025-04-07 19:13","pubTimestamp":1744024388,"startTime":"0","endTime":"0","summary":"Pharvaris ( ($PHVS) ) just unveiled an update. On April 7, 2025, Pharvaris announced its financial results for the fourth quarter and full year of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharvaris-reports-2024-financial-results-and-advances-hae-treatment-studies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharvaris-reports-2024-financial-results-and-advances-hae-treatment-studies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0012050646.USD","IE00BLDYK493.USD","LU1169589451.USD","LU1169590202.USD","LU0205193047.USD","LU0205194284.USD","IE00B64QTZ34.USD","BK4198","HAE","PHVS","BK4007","LU0106261612.USD"],"gpt_icon":0},{"id":"2525019961","title":"Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2525019961","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525019961?lang=en_us&edition=fundamental","pubTime":"2025-04-07 18:58","pubTimestamp":1744023480,"startTime":"0","endTime":"0","summary":"Target enrollment achieved in RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, strengthening confidence in clinical timelinesEnrollment underway in CHAPTE","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/07/3056547/0/en/Pharvaris-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261612.USD","EC","LU0012050646.USD","BK4201","BK4198","LU1169589451.USD","LU0205193047.USD","LU1169590202.USD","LU0205194284.USD","IE00B64QTZ34.USD","HAE","IE00BLDYK493.USD"],"gpt_icon":0},{"id":"2524847414","title":"3 Stocks That May Be Trading Below Their Estimated Value In April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524847414","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524847414?lang=en_us&edition=fundamental","pubTime":"2025-04-03 01:07","pubTimestamp":1743613672,"startTime":"0","endTime":"0","summary":"As the United States stock market navigates a period of volatility amid President Trump's anticipated announcement on new tariffs, major indices like the Dow Jones and S&P 500 have shown resilience with recent gains despite earlier declines. In such an unpredictable environment, identifying stocks that may be trading below their estimated value can offer investors potential opportunities for growth while balancing the risks presented by ongoing economic uncertainties.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Operations: The company generates revenue through its Transitional segment, which accounts for $7.10 million, and Campus Operations, contributing $432.97 million.Overview: MetroCity Bankshares, Inc. is a bank holding company for Metro City Bank, offering various banking products and services in the United States, with a market cap of approximately $700.35 million.Operations: MetroCity Bankshares generates its revenue primarily through its Community Banking","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-stocks-may-trading-below-170752484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1989763427.SGD","BK4198","CINT","LU0471298777.SGD","LU0612318385.USD","IE00B64QTZ34.USD","LU2242646235.USD","LU2242652126.USD","BK4023","LU2401740654.USD","LU0612318971.USD","LINC","IE00BLDYK493.USD","LU0048578792.EUR","BK4539","BK4136","LU1169589451.USD","LU1863844665.USD","LU0654597011.USD","LU2092937221.SGD","LU0205193047.USD","LU0997586606.USD","LU0205194284.USD","LU0385154629.USD","LU0012050646.USD","LU0997587240.USD","BK4196","MCBS","BK4134","BK4211","LU1920062954.HKD","LU0106261612.USD","LU2298321311.HKD","LU1119994140.HKD","LU1803068623.USD","LU2041044095.USD","LU0550127509.SGD","PRVA","LU1169590202.USD","HAE","LU1989763690.USD","LU2242646821.SGD","LU2380233275.USD","SEMR","LU1920063259.USD","LU0471298694.HKD","SW","BHLB","LU1892829315.USD","LU2360106947.USD","LU2360108059.USD","BK4581"],"gpt_icon":0},{"id":"2524497515","title":"3 Reasons to Avoid HAE and 1 Stock to Buy Instead","url":"https://stock-news.laohu8.com/highlight/detail?id=2524497515","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524497515?lang=en_us&edition=fundamental","pubTime":"2025-04-02 17:06","pubTimestamp":1743584797,"startTime":"0","endTime":"0","summary":"Haemonetics has gotten torched over the last six months - since October 2024, its stock price has dropped 20.1% to $63.39 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.Is now the time to buy Haemonetics, or should you be careful about including it in your portfolio?With roots dating back to 1971 and a mission to improve blood-related healthcare, Haemonetics  provides specialized medical devices and software for blood collection, processing, and management across plasma centers, blood banks, and hospitals.Haemonetics isn’t a terrible business, but it doesn’t pass our bar. Following the recent decline, the stock trades at 12.4× forward price-to-earnings . Investors with a higher risk tolerance might like the company, but we don’t really see a big opportunity at the moment. We're pretty confident there are superior stocks to buy right now. We’d recommend looking at the Amazon and PayPal of Latin America.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-reasons-avoid-hae-1-090637517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1169589451.USD","IE00BLDYK493.USD","LU0106261612.USD","LU0012050646.USD","LU0205194284.USD","BK4198","IE00B64QTZ34.USD","HAE","LU0205193047.USD","LU1169590202.USD"],"gpt_icon":0},{"id":"2524414258","title":"Is Intellia Therapeutics, Inc. (NTLA) the Best Gene-Editing Stock to Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524414258","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524414258?lang=en_us&edition=fundamental","pubTime":"2025-04-02 00:41","pubTimestamp":1743525718,"startTime":"0","endTime":"0","summary":"We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Intellia Therapeutics, Inc.  stands against other best gene-editing stocks to buy.Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases. This approach directly alters genetic material to correct mutations, enhance cellular functions, or eliminate disease-causing genes. Industry experts believe that gene editing has the potential to revolutionize the treatment of genetic disorders, cancers, and various other conditions.The number of patients receiving gene therapies is expected to fluctuate over the next decade. In 2020, 16,244 patients were treated, with this figure projected to rise to 94,696 by 2025 before gradually declining to 65,612 by 2034 as existing patient stocks deplete. Over the next decade, an estimated 1.09 million patients could benefit from gene therapies, wi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/intellia-therapeutics-inc-ntla-best-164158104.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4556","USJW.SI","BK4535","HAE","LU1169590202.USD","QID","PSQ","TSYW.SI","SQQQ","BK4585","LU1861559042.SGD","BK4139","BK4588","NTLA","LU0012050646.USD","BK4198","QLD","IE00B64QTZ34.USD","MNQmain","IE00BLDYK493.USD","LU0205194284.USD","USAW.SI","LU0106261612.USD","LU1861558580.USD","LU0205193047.USD","TQQQ","NVIW.SI","NQmain",".IXIC","LU1169589451.USD"],"gpt_icon":1},{"id":"2524191187","title":"Pharvaris Announces Orphan Designation Granted to Deucrictibant by the European Commission","url":"https://stock-news.laohu8.com/highlight/detail?id=2524191187","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524191187?lang=en_us&edition=fundamental","pubTime":"2025-04-01 18:50","pubTimestamp":1743504600,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland, April  01, 2025  (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/01/3053128/0/en/Pharvaris-Announces-Orphan-Designation-Granted-to-Deucrictibant-by-the-European-Commission.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64QTZ34.USD","BK4201","LU0205193047.USD","LU0012050646.USD","EC","LU0106261612.USD","LU0205194284.USD","LU1169590202.USD","BK4198","IE00BLDYK493.USD","LU1169589451.USD","HAE"],"gpt_icon":0},{"id":"2524590330","title":"Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524590330","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524590330?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:00","pubTimestamp":1743451200,"startTime":"0","endTime":"0","summary":"BOSTON, March 31, 2025 /PRNewswire/ -- Haemonetics Corporation  announced that the Company intends to publish fourth quarter and fiscal year 2025 financial results at 6:00 am ET on Thursday, May 8, 2025. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on May 8, 2025.The call can be accessed via teleconference at: Q4 2025 Haemonetics Corporation Earnings Conference Call.Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.A replay of the conference call and webcast will be available for one year beginning on May 8, 2025 at 11:00 am ET using the conference call webcast link provided in this press release.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/haemonetics-sets-date-publishing-fourth-200000896.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/haemonetics-sets-date-publishing-fourth-200000896.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BLDYK493.USD","BK4198","LU0106261612.USD","LU0205193047.USD","LU1169590202.USD","LU0012050646.USD","LU1169589451.USD","HAE","IE00B64QTZ34.USD","LU0205194284.USD"],"gpt_icon":0},{"id":"2524248978","title":"3 Promising Value Stocks Estimated To Be 13.1% To 46.3% Below Intrinsic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2524248978","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524248978?lang=en_us&edition=fundamental","pubTime":"2025-04-01 01:08","pubTimestamp":1743440885,"startTime":"0","endTime":"0","summary":"As the U.S. stock market faces a challenging period with looming tariffs and significant selloffs, investors are increasingly focused on identifying opportunities amidst the broader economic concerns. In such an environment, finding stocks that are trading below their intrinsic value can be particularly appealing, offering potential for long-term growth even as major indices like the S&P 500 and Nasdaq experience notable declines.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Inter & Co. is trading at US$5.65, below its estimated fair value of US$7.46, indicating it may be undervalued based on cash flows. The company reported significant earnings growth with net income rising to BRL 907.13 million in 2024 from BRL 302.34 million the previous year and plans a dividend payout of US$0.08 per share in February 2025, despite having a high bad loans ratio of 8.4%.Operations: The company's revenue segments include Consumer Services at $402.46 million, Money Movement Servi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-promising-value-stocks-estimated-170805516.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4215","UMH","BK4099","BK4023","LU1169589451.USD","BK4524","BK4585","BK4166","BK4211","LU0205194284.USD","LU0205193047.USD","BK4548","BHLB","BK4108","BK4532","LU1861559042.SGD","LU0012050646.USD","LU1861558580.USD","BK4539","LU0106261612.USD","LU1169590202.USD","IE00B64QTZ34.USD","GDOT","SEMR","ROKU","BK4228","BK4507","INTR","IE00BLDYK493.USD","HAE","BK4588","ZK","BK4198"],"gpt_icon":1},{"id":"2523910981","title":"Driven Brands Holdings Among 3 Stocks Priced Below Estimated Fair Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2523910981","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523910981?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:08","pubTimestamp":1743419309,"startTime":"0","endTime":"0","summary":"Amid recent market volatility, driven by concerns over new tariffs and economic data, investors are keenly observing stocks that may be undervalued in the current climate. Identifying stocks priced below their estimated fair value can offer potential opportunities for those looking to navigate these uncertain times effectively.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Driven Brands Holdings appears undervalued based on its cash flows, trading at US$17.86, significantly below the estimated fair value of US$35.09. Despite a net loss of US$292.5 million in 2024, the company has reduced losses from the previous year and is forecast to achieve profitability within three years with earnings growth expected to outpace market averages. However, revenue growth projections at 4.8% annually are slower than broader market expectations of 8.3%.Overview: BeiGene, Ltd. is an oncology company focused on discovering and developing cancer treatments across the United States, Ch","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/driven-brands-holdings-among-3-110829120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1861559042.SGD","SEMR","BK4023","BHLB","BK4532","BK4524","NFG","BK4539","DRVN","BK4108","HAE","IE00B64QTZ34.USD","BK4585","LU1169590202.USD","BK4197","LU0012050646.USD","BK4548","LU0205194284.USD","ROKU","BK4198","LU1861558580.USD","BK4507","BK4137","ZK","LU1169589451.USD","ONC","LU0205193047.USD","BK4099","LU0106261612.USD","IE00BLDYK493.USD","BK4588","BK4211"],"gpt_icon":0},{"id":"2522755938","title":"March 2025 Value Equities That Could Be Trading Below Estimated Worth","url":"https://stock-news.laohu8.com/highlight/detail?id=2522755938","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522755938?lang=en_us&edition=fundamental","pubTime":"2025-03-26 19:07","pubTimestamp":1742987277,"startTime":"0","endTime":"0","summary":"As of March 2025, U.S. stock markets have been experiencing a modest recovery, with major indices like the S&P 500 and Nasdaq Composite showing slight gains after rebounding from a recent selloff driven by tariff concerns and economic uncertainty. In this environment, identifying undervalued stocks can be particularly appealing to investors looking for opportunities that may offer potential growth as the market stabilizes.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Analog Devices is trading at US$213.58, below its estimated fair value of US$260.96, suggesting it may be undervalued based on cash flows. Despite a decrease in profit margins from 24.4% to 16.7%, the company's earnings are forecast to grow significantly at 24.8% annually, outpacing the broader U.S market growth rate of 14%. Recent product innovations and strategic partnerships enhance its competitive edge, though significant insider selling raises caution about potential risks ahead.Overview: Mobiley","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/march-2025-value-equities-could-110757571.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1989763427.SGD","BK4198","LU0612318385.USD","PFS","LU2242646235.USD","SN","LU2401740654.USD","LU0612318971.USD","IE00BLDYK493.USD","LU0048578792.EUR","LU1169589451.USD","LU1863844665.USD","SGXZ23171101.USD","CSTM","LU0654597011.USD","LU2092937221.SGD","LU0205193047.USD","LU0997586606.USD","LU2242644610.SGD","LU0997587240.USD","LU1430597077.USD","MBLY","BK4153","SG9999004303.SGD","BK4157","BK4211","BK4124","LU2298321311.HKD","LU1119994140.HKD","LU1803068623.USD","LU2041044095.USD","LU0550127509.SGD","LU1169590202.USD","HAE","LU1989763690.USD","ADI","LU2362541513.USD","BK4123","KBR","LU2242646821.SGD","LU2380233275.USD","LU1863844749.USD","LU1920063259.USD","BK4195","BK4191","LU0053671581.USD","LU0471298694.HKD","SW","LU1892829315.USD","LU2360106947.USD","LU2360108059.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HAE\",params:#limit:5,,,undefined,":[{"date":"2025-05-08","symbol":"HAE","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":1.22,"defaultRemindTime":1746691200000,"name":null,"time":"Pre-Market","dateTimestamp":1746676800000,"actualEps":null},{"market":"US","date":"2025-02-06","symbol":"HAE","fiscalQuarterEnding":"2024/12","expectedEps":1.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"pre","actualEps":1.19},{"market":"US","date":"2024-11-07","symbol":"HAE","fiscalQuarterEnding":"2024/09","expectedEps":1.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":1.12},{"market":"US","date":"2024-08-08","symbol":"HAE","fiscalQuarterEnding":"2024/06","expectedEps":1.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":1.02},{"market":"US","date":"2024-05-09","symbol":"HAE","fiscalQuarterEnding":"2024/03","expectedEps":0.88,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":0.9}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HAE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HAE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.5,"hold":0.1,"sell":0.1,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":10,"updateTime":1738987200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HAE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HAE","date":"2025-05-02","current":24.32982,"percent":0.019512,"low":21.64539,"twenty":33.384695,"median":44.268479,"eighty":60.816466,"high":144.446304,"avg":50.92674,"sd":23.917692,"marketCap":3164457983},"quantilePoints":[{"date":"2020-05-08","current":67.053969,"twenty":-36.008317,"median":65.577898,"eighty":109.703696,"marketCap":5346682289},{"date":"2020-05-15","current":63.313329,"twenty":-36.008317,"median":65.609438,"eighty":109.703696,"marketCap":5048414877},{"date":"2020-05-22","current":71.202149,"twenty":-36.008317,"median":67.053969,"eighty":109.703696,"marketCap":5448815683},{"date":"2020-05-29","current":72.216125,"twenty":-36.008317,"median":67.855084,"eighty":109.703696,"marketCap":5526411172},{"date":"2020-06-05","current":65.243397,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4992816220},{"date":"2020-06-12","current":58.665725,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4489453277},{"date":"2020-06-19","current":55.946427,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4281356284},{"date":"2020-06-26","current":57.678087,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4413873255},{"date":"2020-07-02","current":60.943878,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4663791193},{"date":"2020-07-10","current":58.066558,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4443601397},{"date":"2020-07-17","current":60.575159,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4635574652},{"date":"2020-07-24","current":60.03525,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4594257573},{"date":"2020-07-31","current":57.717945,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4416923455},{"date":"2020-08-07","current":42.339485,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4044775634},{"date":"2020-08-14","current":44.807253,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4280526532},{"date":"2020-08-21","current":46.006642,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4395106539},{"date":"2020-08-28","current":47.402391,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4528445219},{"date":"2020-09-04","current":47.513839,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4539092034},{"date":"2020-09-11","current":47.09989,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4499546722},{"date":"2020-09-18","current":43.984664,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4201942899},{"date":"2020-09-25","current":46.234844,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4416907160},{"date":"2020-10-02","current":47.121118,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4501574687},{"date":"2020-10-09","current":50.69275,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4842779751},{"date":"2020-10-16","current":49.769326,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4754563286},{"date":"2020-10-23","current":56.758685,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":5422270670},{"date":"2020-10-30","current":53.648765,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":5125173838},{"date":"2020-11-06","current":47.071383,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":4996486123},{"date":"2020-11-13","current":51.419746,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":5458051762},{"date":"2020-11-20","current":55.375847,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":5877980016},{"date":"2020-11-27","current":54.40476,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":5774902101},{"date":"2020-12-04","current":55.318443,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":5871886740},{"date":"2020-12-11","current":56.136452,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":5958715920},{"date":"2020-12-18","current":57.380208,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":6090736895},{"date":"2020-12-24","current":56.806166,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":6029804137},{"date":"2020-12-31","current":56.806166,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":6029804137},{"date":"2021-01-08","current":61.264553,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":6503048554},{"date":"2021-01-15","current":60.130822,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":6382706358},{"date":"2021-01-22","current":55.930753,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":5936881682},{"date":"2021-01-29","current":54.672646,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":5803337388},{"date":"2021-02-05","current":65.436449,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":7075905012},{"date":"2021-02-12","current":63.345002,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":6849748456},{"date":"2021-02-19","current":62.306328,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":6737432503},{"date":"2021-02-26","current":59.4535,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":6428944797},{"date":"2021-03-05","current":56.516074,"twenty":-36.022739,"median":68.530039,"eighty":109.707058,"marketCap":6111309184},{"date":"2021-03-12","current":55.209507,"twenty":-36.022739,"median":68.530039,"eighty":109.707058,"marketCap":5970024864},{"date":"2021-03-19","current":53.550449,"twenty":-36.022739,"median":68.530039,"eighty":109.707058,"marketCap":5790624270},{"date":"2021-03-26","current":54.589123,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":5902940222},{"date":"2021-04-01","current":52.657472,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":5694063043},{"date":"2021-04-09","current":55.016812,"twenty":-36.022739,"median":68.530039,"eighty":109.707058,"marketCap":5949187967},{"date":"2021-04-16","current":54.974513,"twenty":-36.022739,"median":68.530039,"eighty":109.707058,"marketCap":5944614015},{"date":"2021-04-23","current":31.7007,"twenty":-36.022739,"median":68.530039,"eighty":109.707058,"marketCap":3427923530},{"date":"2021-04-30","current":31.611403,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":3418267407},{"date":"2021-05-07","current":28.688076,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":3102156445},{"date":"2021-05-14","current":26.319336,"twenty":-36.008317,"median":68.485883,"eighty":109.703696,"marketCap":2846015088},{"date":"2021-05-21","current":26.394534,"twenty":-35.993895,"median":68.410187,"eighty":109.700335,"marketCap":2854146559},{"date":"2021-05-28","current":36.107074,"twenty":-35.993895,"median":68.410187,"eighty":109.700335,"marketCap":2869393069},{"date":"2021-06-04","current":35.315832,"twenty":-35.993895,"median":68.410187,"eighty":109.700335,"marketCap":2806513877},{"date":"2021-06-11","current":38.515288,"twenty":-35.993895,"median":68.410187,"eighty":109.700335,"marketCap":3060771398},{"date":"2021-06-18","current":40.241958,"twenty":-35.993895,"median":68.410187,"eighty":109.700335,"marketCap":3197988176},{"date":"2021-06-25","current":42.306964,"twenty":-35.993895,"median":68.410187,"eighty":109.700335,"marketCap":3362092111},{"date":"2021-07-02","current":42.710987,"twenty":-35.993895,"median":68.410187,"eighty":109.700335,"marketCap":3394199403},{"date":"2021-07-09","current":40.710112,"twenty":-35.993895,"median":68.410187,"eighty":109.700335,"marketCap":3235191863},{"date":"2021-07-16","current":38.683584,"twenty":-35.993895,"median":68.410187,"eighty":109.700335,"marketCap":3074145765},{"date":"2021-07-23","current":37.875539,"twenty":-35.993895,"median":68.410187,"eighty":109.700335,"marketCap":3009931182},{"date":"2021-07-30","current":38.984998,"twenty":-35.993895,"median":68.410187,"eighty":109.700335,"marketCap":3098098824},{"date":"2021-08-06","current":37.503581,"twenty":-35.993895,"median":67.3946,"eighty":109.700335,"marketCap":2980372088},{"date":"2021-08-13","current":48.318078,"twenty":-35.993895,"median":65.593668,"eighty":109.700335,"marketCap":3115936208},{"date":"2021-08-20","current":47.116843,"twenty":-35.993895,"median":65.410736,"eighty":109.700335,"marketCap":3038470997},{"date":"2021-08-27","current":48.594678,"twenty":-35.993895,"median":65.007443,"eighty":109.700335,"marketCap":3133773592},{"date":"2021-09-03","current":51.028758,"twenty":-35.993895,"median":64.365454,"eighty":109.700335,"marketCap":3290742574},{"date":"2021-09-10","current":53.320587,"twenty":-35.993895,"median":63.662493,"eighty":109.700335,"marketCap":3438538043},{"date":"2021-09-17","current":55.493874,"twenty":-35.993895,"median":63.358892,"eighty":109.700335,"marketCap":3578688920},{"date":"2021-09-24","current":54.916965,"twenty":-35.993895,"median":63.068193,"eighty":109.700335,"marketCap":3541485232},{"date":"2021-10-01","current":56.900582,"twenty":-35.993895,"median":62.475524,"eighty":109.700335,"marketCap":3669404760},{"date":"2021-10-08","current":53.344296,"twenty":-35.993895,"median":61.853028,"eighty":109.700335,"marketCap":3440066962},{"date":"2021-10-15","current":55.248885,"twenty":-35.993895,"median":61.375039,"eighty":109.700335,"marketCap":3562890094},{"date":"2021-10-22","current":56.703011,"twenty":-35.993895,"median":61.047856,"eighty":109.700335,"marketCap":3656663771},{"date":"2021-10-29","current":54.300542,"twenty":-35.993895,"median":60.807745,"eighty":109.700335,"marketCap":3501733348},{"date":"2021-11-05","current":58.947423,"twenty":-35.993895,"median":60.537162,"eighty":109.700335,"marketCap":3801401403},{"date":"2021-11-12","current":98.0786,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":3064269710},{"date":"2021-11-19","current":91.879169,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2870580881},{"date":"2021-11-26","current":84.9273,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2653383645},{"date":"2021-12-03","current":86.317674,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2696823092},{"date":"2021-12-10","current":84.812799,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2649806279},{"date":"2021-12-17","current":86.890181,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2714709923},{"date":"2021-12-23","current":88.591344,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2767859365},{"date":"2021-12-31","current":86.759322,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2710621505},{"date":"2022-01-07","current":86.088671,"twenty":-35.979473,"median":60.499165,"eighty":109.696973,"marketCap":2689668360},{"date":"2022-01-14","current":86.186815,"twenty":-35.979473,"median":60.499165,"eighty":109.696973,"marketCap":2692734674},{"date":"2022-01-21","current":80.249102,"twenty":-35.979473,"median":60.499165,"eighty":109.696973,"marketCap":2507222681},{"date":"2022-01-28","current":75.178327,"twenty":-35.965051,"median":60.537162,"eighty":109.693612,"marketCap":2348796462},{"date":"2022-02-04","current":76.241554,"twenty":-35.965051,"median":60.537162,"eighty":109.693612,"marketCap":2382014863},{"date":"2022-02-11","current":132.27526,"twenty":-34.668681,"median":60.807745,"eighty":111.039755,"marketCap":2988494959},{"date":"2022-02-18","current":125.601547,"twenty":-34.469979,"median":61.047856,"eighty":111.532645,"marketCap":2837715754},{"date":"2022-02-25","current":129.379548,"twenty":-34.311338,"median":61.359457,"eighty":111.98412,"marketCap":2923072118},{"date":"2022-03-04","current":132.003787,"twenty":-34.051744,"median":61.783676,"eighty":112.835267,"marketCap":2982361568},{"date":"2022-03-11","current":121.778301,"twenty":-33.85785,"median":62.188491,"eighty":113.319081,"marketCap":2751337158},{"date":"2022-03-18","current":129.583152,"twenty":-33.51653,"median":62.994775,"eighty":114.080433,"marketCap":2927672161},{"date":"2022-03-25","current":134.4018,"twenty":-33.327443,"median":63.351243,"eighty":114.297089,"marketCap":3036539858},{"date":"2022-04-01","current":144.446304,"twenty":12.858807,"median":63.591935,"eighty":114.85374,"marketCap":3263475340},{"date":"2022-04-08","current":135.329333,"twenty":26.526131,"median":64.365454,"eighty":118.412035,"marketCap":3057495612},{"date":"2022-04-14","current":128.542506,"twenty":27.793219,"median":64.890745,"eighty":123.456909,"marketCap":2904160827},{"date":"2022-04-22","current":122.185511,"twenty":29.124226,"median":65.319181,"eighty":124.18094,"marketCap":2760537245},{"date":"2022-04-29","current":114.62951,"twenty":31.542784,"median":65.565922,"eighty":124.252941,"marketCap":2589824518},{"date":"2022-05-06","current":117.366864,"twenty":32.033452,"median":67.0792,"eighty":124.252941,"marketCap":2651669548},{"date":"2022-05-13","current":66.271265,"twenty":35.464129,"median":67.3946,"eighty":124.252941,"marketCap":2874516102},{"date":"2022-05-20","current":69.90063,"twenty":36.481486,"median":68.104166,"eighty":124.252941,"marketCap":3031939815},{"date":"2022-05-27","current":75.603918,"twenty":37.198319,"median":69.227072,"eighty":124.252941,"marketCap":3279319935},{"date":"2022-06-03","current":76.004562,"twenty":37.61535,"median":69.681162,"eighty":124.252941,"marketCap":3296697877},{"date":"2022-06-10","current":76.26261,"twenty":38.029161,"median":70.362161,"eighty":124.252941,"marketCap":3307890688},{"date":"2022-06-17","current":71.841246,"twenty":38.485794,"median":71.159351,"eighty":124.252941,"marketCap":3116114046},{"date":"2022-06-24","current":77.149247,"twenty":38.879824,"median":71.841246,"eighty":124.324942,"marketCap":3346348571},{"date":"2022-07-01","current":79.584543,"twenty":39.929153,"median":72.054039,"eighty":124.324942,"marketCap":3451979555},{"date":"2022-07-08","current":78.969808,"twenty":40.349299,"median":72.422071,"eighty":124.324942,"marketCap":3425315423},{"date":"2022-07-15","current":75.798905,"twenty":40.806308,"median":73.633206,"eighty":124.324942,"marketCap":3287777520},{"date":"2022-07-22","current":78.187949,"twenty":41.868556,"median":74.543389,"eighty":124.324942,"marketCap":3391402276},{"date":"2022-07-29","current":82.185457,"twenty":42.602719,"median":74.985852,"eighty":124.324942,"marketCap":3564794194},{"date":"2022-08-05","current":82.291899,"twenty":43.849716,"median":75.3419,"eighty":124.324942,"marketCap":3569411138},{"date":"2022-08-12","current":56.977427,"twenty":44.747815,"median":75.512988,"eighty":124.324942,"marketCap":3857713676},{"date":"2022-08-19","current":57.936321,"twenty":45.53495,"median":75.512988,"eighty":124.324942,"marketCap":3922636546},{"date":"2022-08-26","current":56.94343,"twenty":46.060774,"median":75.512988,"eighty":124.324942,"marketCap":3855411875},{"date":"2022-09-02","current":55.889905,"twenty":46.344767,"median":75.512988,"eighty":124.324942,"marketCap":3784081880},{"date":"2022-09-09","current":58.262232,"twenty":46.74555,"median":75.512988,"eighty":124.324942,"marketCap":3944702660},{"date":"2022-09-16","current":58.186439,"twenty":47.088487,"median":75.512988,"eighty":124.324942,"marketCap":3939571006},{"date":"2022-09-23","current":55.889905,"twenty":47.296251,"median":75.512988,"eighty":124.324942,"marketCap":3784081880},{"date":"2022-09-30","current":56.109705,"twenty":47.555234,"median":75.512988,"eighty":124.324942,"marketCap":3798963678},{"date":"2022-10-07","current":57.557355,"twenty":48.010942,"median":75.512988,"eighty":124.324942,"marketCap":3896978275},{"date":"2022-10-14","current":58.012114,"twenty":48.76538,"median":75.512988,"eighty":124.324942,"marketCap":3927768201},{"date":"2022-10-21","current":60.649717,"twenty":49.274711,"median":75.512988,"eighty":124.324942,"marketCap":4106349770},{"date":"2022-10-28","current":63.272162,"twenty":49.733238,"median":75.512988,"eighty":124.324942,"marketCap":4283905009},{"date":"2022-11-04","current":61.134794,"twenty":50.311585,"median":75.512988,"eighty":124.324942,"marketCap":4139192358},{"date":"2022-11-11","current":46.610721,"twenty":50.311585,"median":75.512988,"eighty":124.324942,"marketCap":4010712688},{"date":"2022-11-18","current":47.010661,"twenty":50.311585,"median":75.512988,"eighty":124.324942,"marketCap":4045126374},{"date":"2022-11-25","current":49.145638,"twenty":50.311585,"median":75.512988,"eighty":124.324942,"marketCap":4228834728},{"date":"2022-12-02","current":50.66306,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":4359404302},{"date":"2022-12-09","current":47.134172,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":4055754130},{"date":"2022-12-16","current":46.069625,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":3964152995},{"date":"2022-12-23","current":46.56955,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":4007170103},{"date":"2022-12-30","current":46.257832,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":3980347671},{"date":"2023-01-06","current":43.287685,"twenty":50.066658,"median":75.178327,"eighty":123.589501,"marketCap":3724775443},{"date":"2023-01-13","current":50.410156,"twenty":49.925919,"median":74.62356,"eighty":121.823547,"marketCap":4337642707},{"date":"2023-01-20","current":52.53337,"twenty":49.925919,"median":74.252899,"eighty":117.448306,"marketCap":4520338893},{"date":"2023-01-27","current":50.098438,"twenty":49.925919,"median":73.400375,"eighty":115.406743,"marketCap":4310820275},{"date":"2023-02-03","current":51.245326,"twenty":49.800935,"median":72.34781,"eighty":114.777933,"marketCap":4409506581},{"date":"2023-02-10","current":42.450958,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4065061322},{"date":"2023-02-17","current":42.819731,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4100374588},{"date":"2023-02-24","current":41.565905,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3980309485},{"date":"2023-03-03","current":41.091769,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3934906716},{"date":"2023-03-10","current":39.695703,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3801220782},{"date":"2023-03-17","current":40.359493,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3864784660},{"date":"2023-03-24","current":40.786215,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3905647153},{"date":"2023-03-31","current":43.594152,"twenty":49.766923,"median":72.183716,"eighty":114.652068,"marketCap":4174532445},{"date":"2023-04-06","current":44.431792,"twenty":49.766923,"median":72.183716,"eighty":114.652068,"marketCap":4254744005},{"date":"2023-04-14","current":45.048169,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4313767606},{"date":"2023-04-21","current":44.268479,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4239105273},{"date":"2023-04-28","current":43.615225,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4176550346},{"date":"2023-05-05","current":42.587931,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4078177678},{"date":"2023-05-12","current":37.524937,"twenty":49.634964,"median":72.006752,"eighty":114.674627,"marketCap":4330415288},{"date":"2023-05-19","current":36.432063,"twenty":49.470785,"median":71.609259,"eighty":114.674627,"marketCap":4204296483},{"date":"2023-05-26","current":36.297944,"twenty":49.138253,"median":70.90224,"eighty":114.674627,"marketCap":4188819017},{"date":"2023-06-02","current":37.914008,"twenty":48.900494,"median":70.079794,"eighty":114.674627,"marketCap":4375314458},{"date":"2023-06-09","current":38.684814,"twenty":48.81157,"median":69.523462,"eighty":114.697185,"marketCap":4464266214},{"date":"2023-06-16","current":36.5432,"twenty":48.359383,"median":68.782359,"eighty":114.697185,"marketCap":4217121848},{"date":"2023-06-23","current":37.41357,"twenty":48.034039,"median":67.855084,"eighty":114.719744,"marketCap":4317563349},{"date":"2023-06-30","current":37.198726,"twenty":47.795111,"median":67.0792,"eighty":114.742302,"marketCap":4292770122},{"date":"2023-07-07","current":36.199043,"twenty":47.513839,"median":65.87122,"eighty":114.742302,"marketCap":4177405720},{"date":"2023-07-14","current":37.571414,"twenty":47.13704,"median":65.431477,"eighty":114.742302,"marketCap":4335778781},{"date":"2023-07-21","current":40.517848,"twenty":47.09989,"median":65.085875,"eighty":114.742302,"marketCap":4675800177},{"date":"2023-07-28","current":40.991382,"twenty":46.893622,"median":64.463228,"eighty":114.62951,"marketCap":4730446472},{"date":"2023-08-04","current":40.180236,"twenty":46.640128,"median":63.848761,"eighty":114.62951,"marketCap":4636839392},{"date":"2023-08-11","current":33.780528,"twenty":46.453003,"median":63.523476,"eighty":114.197827,"marketCap":4613271549},{"date":"2023-08-18","current":32.135505,"twenty":46.303836,"median":63.329166,"eighty":113.741296,"marketCap":4388617345},{"date":"2023-08-25","current":32.090944,"twenty":46.104914,"median":62.994775,"eighty":112.790968,"marketCap":4382531904},{"date":"2023-09-01","current":33.32007,"twenty":45.899062,"median":62.338276,"eighty":111.980393,"marketCap":4550388657},{"date":"2023-09-08","current":32.644236,"twenty":45.588443,"median":61.963237,"eighty":111.151185,"marketCap":4458092799},{"date":"2023-09-15","current":33.442611,"twenty":45.332649,"median":61.591282,"eighty":108.66356,"marketCap":4567123620},{"date":"2023-09-22","current":33.453751,"twenty":45.027096,"median":61.359457,"eighty":104.4523,"marketCap":4568644980},{"date":"2023-09-29","current":33.851082,"twenty":44.674128,"median":61.088808,"eighty":100.62634,"marketCap":4622906831},{"date":"2023-10-06","current":32.506842,"twenty":44.409226,"median":60.907196,"eighty":99.38139,"marketCap":4439329355},{"date":"2023-10-13","current":32.562542,"twenty":44.268479,"median":60.628899,"eighty":98.805587,"marketCap":4446936156},{"date":"2023-10-20","current":33.568866,"twenty":43.94712,"median":60.337322,"eighty":98.141199,"marketCap":4584365704},{"date":"2023-10-27","current":31.025207,"twenty":43.721642,"median":60.270751,"eighty":97.618547,"marketCap":4236988435},{"date":"2023-11-03","current":33.805375,"twenty":43.615225,"median":59.995745,"eighty":97.24472,"marketCap":4336452084},{"date":"2023-11-10","current":33.852843,"twenty":43.397999,"median":59.590266,"eighty":96.788062,"marketCap":4342541181},{"date":"2023-11-17","current":35.292717,"twenty":43.09473,"median":59.300599,"eighty":96.510871,"marketCap":4527243797},{"date":"2023-11-24","current":32.41297,"twenty":42.882949,"median":59.047612,"eighty":96.179039,"marketCap":4157838565},{"date":"2023-12-01","current":31.989711,"twenty":42.721248,"median":58.920552,"eighty":96.025608,"marketCap":4103544114},{"date":"2023-12-08","current":32.935122,"twenty":42.386415,"median":58.853577,"eighty":95.310906,"marketCap":4224818635},{"date":"2023-12-15","current":35.110755,"twenty":42.308016,"median":58.70523,"eighty":94.9012,"marketCap":4503902258},{"date":"2023-12-22","current":33.821198,"twenty":41.984872,"median":58.322866,"eighty":94.533572,"marketCap":4338481783},{"date":"2023-12-29","current":34.378951,"twenty":41.734279,"median":58.224335,"eighty":94.358582,"marketCap":4410028676},{"date":"2024-01-05","current":32.361546,"twenty":41.565905,"median":58.012114,"eighty":94.027739,"marketCap":4151242043},{"date":"2024-01-12","current":32.765027,"twenty":41.050004,"median":57.901951,"eighty":93.689799,"marketCap":4202999369},{"date":"2024-01-19","current":33.030059,"twenty":40.916657,"median":57.809931,"eighty":92.879374,"marketCap":4236996829},{"date":"2024-01-26","current":32.132116,"twenty":40.786215,"median":57.557355,"eighty":92.217147,"marketCap":4121811406},{"date":"2024-02-02","current":30.854426,"twenty":40.645981,"median":57.415067,"eighty":91.542793,"marketCap":3957913206},{"date":"2024-02-09","current":31.340588,"twenty":40.530546,"median":57.27692,"eighty":90.845062,"marketCap":3966903598},{"date":"2024-02-16","current":28.840884,"twenty":40.391805,"median":57.021432,"eighty":90.511809,"marketCap":3650506089},{"date":"2024-02-23","current":30.052619,"twenty":40.28554,"median":56.959244,"eighty":90.267746,"marketCap":3803880163},{"date":"2024-03-01","current":29.282245,"twenty":40.169713,"median":56.86082,"eighty":89.975454,"marketCap":3706370818},{"date":"2024-03-08","current":31.196143,"twenty":39.686358,"median":56.779913,"eighty":89.650338,"marketCap":3948620596},{"date":"2024-03-15","current":30.333484,"twenty":39.199647,"median":56.623635,"eighty":89.309009,"marketCap":3839430445},{"date":"2024-03-22","current":32.215284,"twenty":38.802962,"median":56.576565,"eighty":89.042645,"marketCap":4077617333},{"date":"2024-03-28","current":33.739983,"twenty":38.68383,"median":56.517971,"eighty":88.628965,"marketCap":4270604578},{"date":"2024-04-05","current":34.060972,"twenty":38.430798,"median":56.447391,"eighty":88.026299,"marketCap":4311233472},{"date":"2024-04-12","current":34.714988,"twenty":38.170539,"median":56.213034,"eighty":87.780769,"marketCap":4394014842},{"date":"2024-04-19","current":33.487204,"twenty":37.914008,"median":56.109705,"eighty":87.462688,"marketCap":4238609324},{"date":"2024-04-26","current":35.172397,"twenty":37.610343,"median":55.996257,"eighty":87.410344,"marketCap":4451911016},{"date":"2024-05-03","current":37.447409,"twenty":37.448115,"median":55.925691,"eighty":87.031236,"marketCap":4739868299},{"date":"2024-05-10","current":40.004036,"twenty":37.42173,"median":55.823822,"eighty":86.74189,"marketCap":4702794434},{"date":"2024-05-17","current":40.954456,"twenty":37.42173,"median":55.726494,"eighty":86.304612,"marketCap":4814523891},{"date":"2024-05-24","current":38.334996,"twenty":37.42173,"median":55.579945,"eighty":86.083348,"marketCap":4506585418},{"date":"2024-05-31","current":36.609402,"twenty":37.413918,"median":55.43486,"eighty":85.929862,"marketCap":4303728065},{"date":"2024-06-07","current":37.873064,"twenty":37.403047,"median":55.250346,"eighty":85.523848,"marketCap":4452281703},{"date":"2024-06-14","current":37.296603,"twenty":37.244592,"median":55.138245,"eighty":85.094818,"marketCap":4384514082},{"date":"2024-06-21","current":37.058217,"twenty":37.126478,"median":55.022209,"eighty":84.728755,"marketCap":4356489879},{"date":"2024-06-28","current":36.052661,"twenty":37.09896,"median":54.946314,"eighty":83.535921,"marketCap":4238278691},{"date":"2024-07-05","current":36.464419,"twenty":37.043719,"median":54.885353,"eighty":82.319567,"marketCap":4286684134},{"date":"2024-07-12","current":38.791935,"twenty":37.017445,"median":54.609,"eighty":81.867773,"marketCap":4560302271},{"date":"2024-07-15","current":39.260039,"twenty":37.017445,"median":54.589123,"eighty":81.773605,"marketCap":4615331616},{"date":"2024-08-02","current":39.064995,"twenty":36.955248,"median":54.288688,"eighty":80.360332,"marketCap":4592402722},{"date":"2024-08-09","current":34.046029,"twenty":36.92102,"median":54.107954,"eighty":79.911493,"marketCap":3911514209},{"date":"2024-08-16","current":32.959122,"twenty":36.827919,"median":53.974996,"eighty":79.219819,"marketCap":3786640538},{"date":"2024-08-23","current":33.631757,"twenty":36.777806,"median":53.857029,"eighty":78.263641,"marketCap":3863918917},{"date":"2024-08-30","current":33.578302,"twenty":36.705542,"median":53.663055,"eighty":77.612662,"marketCap":3857777588},{"date":"2024-09-06","current":33.221939,"twenty":36.5432,"median":53.423229,"eighty":77.092502,"marketCap":3816835401},{"date":"2024-09-13","current":32.633941,"twenty":36.479103,"median":53.275733,"eighty":76.801829,"marketCap":3749280792},{"date":"2024-09-20","current":33.444666,"twenty":36.348592,"median":52.83765,"eighty":76.249976,"marketCap":3842424268},{"date":"2024-09-27","current":34.099483,"twenty":36.143985,"median":52.576392,"eighty":75.985907,"marketCap":3917655537},{"date":"2024-10-04","current":34.781028,"twenty":35.815644,"median":52.005614,"eighty":75.653859,"marketCap":3995957470},{"date":"2024-10-11","current":33.16403,"twenty":35.398884,"median":51.644579,"eighty":75.347255,"marketCap":3810182296},{"date":"2024-10-18","current":33.827757,"twenty":35.286388,"median":51.321786,"eighty":74.99485,"marketCap":3886437119},{"date":"2024-10-25","current":33.769848,"twenty":35.073467,"median":50.961335,"eighty":74.557795,"marketCap":3879784014},{"date":"2024-10-31","current":32.081578,"twenty":34.946551,"median":50.677905,"eighty":73.643703,"marketCap":3685820402},{"date":"2024-11-08","current":35.100579,"twenty":34.791083,"median":50.174897,"eighty":72.654053,"marketCap":4345872942},{"date":"2024-11-15","current":36.812407,"twenty":34.791083,"median":50.02786,"eighty":72.052383,"marketCap":4557817745},{"date":"2024-11-22","current":34.654368,"twenty":34.70383,"median":49.822008,"eighty":71.813687,"marketCap":4290626666},{"date":"2024-11-29","current":35.481887,"twenty":34.699053,"median":49.663186,"eighty":71.167911,"marketCap":4393083395},{"date":"2024-12-06","current":32.723492,"twenty":34.589092,"median":49.471895,"eighty":70.134049,"marketCap":4051560964},{"date":"2024-12-13","current":33.384695,"twenty":34.425584,"median":49.145638,"eighty":69.703258,"marketCap":4133425900},{"date":"2024-12-20","current":31.194205,"twenty":34.307596,"median":48.886853,"eighty":69.013231,"marketCap":3862216910},{"date":"2024-12-27","current":31.985215,"twenty":34.216342,"median":48.780986,"eighty":68.150231,"marketCap":3960153489},{"date":"2025-01-03","current":31.802675,"twenty":34.159174,"median":48.421341,"eighty":67.685601,"marketCap":3937552740},{"date":"2025-01-10","current":31.680981,"twenty":34.09592,"median":48.051683,"eighty":66.243612,"marketCap":3922485574},{"date":"2025-01-17","current":29.827177,"twenty":34.062068,"median":47.691624,"eighty":65.473912,"marketCap":3692962411},{"date":"2025-01-24","current":29.555394,"twenty":34.038606,"median":47.505878,"eighty":65.235863,"marketCap":3659312406},{"date":"2025-01-31","current":28.180253,"twenty":33.968145,"median":47.135606,"eighty":64.762279,"marketCap":3489053429},{"date":"2025-02-07","current":24.323243,"twenty":33.900182,"median":47.085636,"eighty":64.253801,"marketCap":3163602642},{"date":"2025-02-14","current":24.059445,"twenty":33.848111,"median":46.893327,"eighty":63.64383,"marketCap":3129291757},{"date":"2025-02-21","current":24.507494,"twenty":33.805614,"median":46.748088,"eighty":63.36814,"marketCap":3187567217},{"date":"2025-02-28","current":24.940093,"twenty":33.751655,"median":46.4766,"eighty":63.305096,"marketCap":3243833179},{"date":"2025-03-07","current":25.955928,"twenty":33.698834,"median":46.303836,"eighty":62.823315,"marketCap":3375957715},{"date":"2025-03-14","current":25.465391,"twenty":33.671773,"median":46.104914,"eighty":62.370223,"marketCap":3312156133},{"date":"2025-03-21","current":24.812631,"twenty":33.631757,"median":45.899062,"eighty":62.370223,"marketCap":3227254815},{"date":"2025-03-28","current":24.801043,"twenty":33.568866,"median":45.463832,"eighty":62.195899,"marketCap":3225747691},{"date":"2025-04-04","current":24.032408,"twenty":33.538212,"median":45.269432,"eighty":61.915464,"marketCap":3125775134},{"date":"2025-04-11","current":22.892974,"twenty":33.466383,"median":44.987585,"eighty":61.454392,"marketCap":2977574609},{"date":"2025-04-17","current":21.973701,"twenty":33.444666,"median":44.72681,"eighty":61.359919,"marketCap":2858009440},{"date":"2025-04-25","current":23.916533,"twenty":33.40903,"median":44.409226,"eighty":61.030153,"marketCap":3110703894},{"date":"2025-05-02","current":24.32982,"twenty":33.384695,"median":44.268479,"eighty":60.816466,"marketCap":3164457983}],"updateTime":1746315333665}}}